Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
$707M |
| 2 |
Meta Platforms (Facebook)
META
|
$479M |
| 3 |
Evergy
EVRG
|
$302M |
| 4 |
Johnson & Johnson
JNJ
|
$298M |
| 5 |
Walmart
WMT
|
$266M |
Top Sells
| 1 |
Home Depot
HD
|
$623M |
| 2 |
Amazon
AMZN
|
$555M |
| 3 |
Booking.com
BKNG
|
$519M |
| 4 |
Eli Lilly
LLY
|
$279M |
| 5 |
UnitedHealth
UNH
|
$251M |
Sector Composition
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.44% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.47% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Align Technology
ALGN
$10.3B
| $990M | 1.08% | 2,894,800 -63,800 | -2% | -$21.8M |
|
2
Domino's
DPZ
$15.6B
| $974M | 1.06% | 3,451,500 -80,600 | -2% | -$22.7M |
|
3
VeriSign
VRSN
$25.5B
| $950M | 1.04% | 6,915,100 -11,776 | -0.2% | -$1.62M |
|
4
Novo Nordisk
NVO
$251B
| $883M | 0.96% | 19,142,300 +2,051,000 | +12% | +$94.6M |
|
5
Humana
HUM
$36.5B
| $828M | 0.9% | 2,783,500 -465,600 | -14% | -$139M |
|
|
VMW
6
DELISTED
VMware, Inc
VMW
| $777M | 0.85% | 5,289,800 +1,512,500 | +40% | +$222M |
|
7
Palo Alto Networks
PANW
$127B
| $766M | 0.83% | 3,725,700 -720,400 | -16% | -$148M |
|
8
PepsiCo
PEP
$204B
| $758M | 0.83% | 6,962,850 -2,115,412 | -23% | -$230M |
|
|
9
Apple
AAPL
$3.45T
| $707M | 0.77% | +3,818,833 | New | +$707M |
|
10
Amgen
AMGN
$155B
| $702M | 0.77% | 3,803,600 -121,700 | -3% | -$22.5M |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $688M | 0.75% | 4,050,617 +1,199,700 | +42% | +$204M |
|
|
ABMD
12
DELISTED
Abiomed Inc
ABMD
| $635M | 0.69% | 1,551,423 +401,800 | +35% | +$164M |
|
13
Bristol-Myers Squibb
BMY
$96B
| $584M | 0.64% | 10,547,200 -3,981,100 | -27% | -$220M |
|
14
Crown Castle
CCI
$43.2B
| $570M | 0.62% | 5,289,703 -491,200 | -8% | -$53M |
|
15
Intuitive Surgical
ISRG
$170B
| $562M | 0.61% | 1,174,410 -307,600 | -21% | -$147M |
|
16
Cboe Global Markets
CBOE
$24.7B
| $540M | 0.59% | 5,190,200 +683,700 | +15% | +$71.2M |
|
|
17
Meta Platforms (Facebook)
META
$1.86T
| $479M | 0.52% | +2,467,488 | New | +$479M |
|
18
Idexx Laboratories
IDXX
$51.8B
| $473M | 0.52% | 2,169,929 +81,025 | +4% | +$17.7M |
|
19
Dell
DELL
$82.6B
| $469M | 0.51% | 5,549,700 +794,800 | +17% | +$67.2M |
|
20
Colgate-Palmolive
CL
$67.9B
| $467M | 0.51% | 7,200,900 -2,022,700 | -22% | -$131M |
|
|
21
Johnson & Johnson
JNJ
$427B
| $454M | 0.49% | 3,740,300 +2,455,901 | +191% | +$298M |
|
22
FirstEnergy
FE
$25.2B
| $431M | 0.47% | 12,007,408 +2,251,708 | +23% | +$80.9M |
|
23
Progressive
PGR
$145B
| $420M | 0.46% | 7,094,900 +1,163,500 | +20% | +$68.8M |
|
24
BP
BP
$90.8B
| $414M | 0.45% | 9,057,544 +1,714,700 | +23% | +$78.3M |
|
25
Best Buy
BBY
$15.6B
| $394M | 0.43% | 5,279,100 -264,000 | -5% | -$19.7M |
|